Cognitive fMRI and soluble telencephalin assessment in patients with localization-related epilepsy

Acta Neurologica Scandinavica

Volumn 118, Issue 4, 2008, Pages 232-239

  Jansen, J F A ^a,b   Vlooswijk, M C G ^a   De Baets, M H ^a   De Krom, M C T F M ^a   Rieckmann, P ^c   Backes, W H ^a   Aldenkamp, A P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cognition; Epilepsy; Functional magnetic resonance imaging; Levetiracetam; Neuropsychology; Telencephalin

Indexed keywords

CARBAMAZEPINE; CELL ADHESION MOLECULE; CLOBAZAM; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; TELENCEPHALIN; TOPIRAMATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; EPILEPSY; EPILEPTIC FOCUS; FEMALE; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; TEMPORAL LOBE; VERBAL MEMORY; WORKING MEMORY;

ADULT; ANTICONVULSANTS; BIOLOGICAL MARKERS; BRAIN; CELL ADHESION MOLECULES; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; PIRACETAM;

EID: 51349088976     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01005.x     Document Type: Article

References (28)

1. Thompson PJ, Corcoran R. Everyday memory failures in people with epilepsy. Epilepsia 1992 33 (Suppl. 6 S18 20.
2. Rieckmann P, Turner T, Kligannon P, Steinhoff BJ. Telencephalin as an indicator for temporal-lobe dysfunction. Lancet 1998 352 : 370 1.
3. Guo H, Tong N, Turner T et al. Release of the neuronal glycoprotein ICAM-5 in serum after hypoxic-ischemic injury. Ann Neurol 2000 48 : 590 602.
4. Godefroy O. Frontal syndrome and disorders of executive functions. J Neurol 2003 250 : 1 6.
5. D'esposito M, Chen AJ. Neural mechanisms of prefrontal cortical function: implications for cognitive rehabilitation. Prog Brain Res 2006 157 : 123 39.
6. Jansen JF, Aldenkamp AP, Marian Majoie HJ et al. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy Behav 2006 9 : 181 5.
7. Cheung MC, Chan AS, Chan YL, Lam JM, Lam W. Effects of illness duration on memory processing of patients with temporal lobe epilepsy. Epilepsia 2006 47 : 1320 8.
8. Manoach DS, Schlaug G, Siewert B et al. Prefrontal cortex fMRI signal changes are correlated with working memory load. Neuroreport 1997 8 : 545 9.
9. Hillary FG, Chiaravalloti ND, Ricker JH et al. An investigation of working memory rehearsal in multiple sclerosis using fMRI. J Clin Exp Neuropsychol 2003 25 : 965 78.
10. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935 18 : 643 62.
11. Marsh R, Zhu H, Schultz RT et al. A developmental fMRI study of self-regulatory control. Hum Brain Mapp 2006 27 : 848 63.
12. Aldenkamp AP, Vermeulen J, Alpherts WCJ, Overweg J, Van Parijs JAP, Verhoeff NPLG. Validity of computerized testing: patient dysfunction and complaints versus measured changes. In : Dodson WE, Kinsbourne M, eds. Assessment of cognitive function. New York : Demos, 1992 51 68.
13. Sternberg S. High-speed scanning in human memory. Science 1966 153 : 652 4.
14. Stroop JD. Studies of interference in serial verbal reactions. J Exp Psychol 1935 18 : 643 62.
15. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the brain. 3-D proportional system: an approach to cerebral imaging. New York : Thieme Medical Publishers, 1988.
16. Seghier ML, Lazeyras F, Pegna AJ, Annoni JM, Khateb A. Group analysis and the subject factor in functional magnetic resonance imaging: analysis of fifty right-handed healthy subjects in a semantic language task. Hum Brain Mapp. 2007 epub ahead of print S, Jansen A, Frank A et al. How atypical is atypical language dominance? Neuroimage 2003 18 : 917 27.
17. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003 19 : 1233 9.
18. O'brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984 40 : 1079 87.
19. Läuter J. Exact T and F tests for analyzing studies with multiple endpoints. Biometrics 1996 52 : 964 70.
20. Lindsberg PJ, Launes J, Tian L et al. Release of soluble ICAM-5, a neuronal adhesion molecule, in acute encephalitis. Neurology 2002 58 : 446 51.
21. Nakamura K, Manabe T, Watanabe M et al. Enhancement of hippocampal LTP, reference memory and sensorimotor gating in mutant mice lacking a telencephalin-specific cell adhesion molecule. Eur J Neurosci 2001 13 : 179 89.
22. Laskowitz DT, Grocott H, Hsia A, Copeland KR. Serum markers of cerebral ischemia. J Stroke Cerebrovasc Dis 1998 7 : 234 41.
23. Correale J, Rabinowicz AL, Heck CN, Smith TD, Loskota WJ, Degiorgio CM. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier. Neurology 1998 50 : 1388 91.
24. Willert C, Spitzer C, Kusserow S, Runge U. Serum neuron-specific enolase, prolactin, and creatine kinase after epileptic and psychogenic non-epileptic seizures. Acta Neurol Scand 2004 109 : 318 23.
25. Barker PB. N-acetyl aspartate - a neuronal marker? Ann Neurol 2001 49 : 423 4.
26. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000 13 : 129 53.
27. Sirsi D, Safdieh JE. The safety of levetiracetam. Expert Opin Drug Saf 2007 6 : 241 50.
28. Piazzini A, Chifari R, Canevini MP, Turner K, Fontana SP, Canger R. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res 2006 68 : 181 8.